Healthcare
SIGA Technologies, Inc.(SIGA)
Live Price
Offline$4.32
+0.23% today
1Y Change
-23.53%
Window
Jun 20, 2025 โ May 29, 2026
- Market Cap
- $330.00M
- Revenue Growth
- -31.8%
- EPS Growth
- -60.2%
- Dividend Yield
- 13.0%
Coverage: 237 bars ยท Jun 20, 2025 โ May 29, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
SIGA Technologies, Inc. (SIGA) is a Healthcare stock with a market cap of $330.00M and listed on NASDAQ. The stock last traded around $4.32 and down 23.5% across the available one-year price window (Jun 20, 2025 โ May 29, 2026). Baseline metrics include revenue growth of -31.8%, EPS growth of -60.2%, a dividend yield of 13.0%. What stands out right now is revenue -31.8%, EPS -60.2%, free cash flow 0.0% with operating margin 25.1% and ROIC 9.0%. The dividend matters to the case here, with a current yield around 13.0%. Valuation is more restrained than many high-expectation growth names at P/E 14.1 and price/sales 3.5. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines SIGA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-31.8% vs +7.6% peer median
Operating Margin
Above sector median
+25.1% vs +19.4% peer median
P/E
Below sector median
14.1 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 7, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -31.8% and EPS is at -60.2%, with operating margin around 25.1%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 13.0%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -15.6% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 7, 2026 | โ | +1.5% | -9.9% | โ |
2026 Mar 10, 2026 | โ | -3.0% | -11.2% | -18.9% |
2025 Nov 6, 2025 | โ | -20.0% | -25.6% | -24.1% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SIGA
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SIGA Max Drawdown
-56.01%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SIGA and SPY.
Company Overview
SIGA Technologies, Inc.
NASDAQ Global Market
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
- Leadership
- Diem Nguyen
- IPO Date
- Sep 10, 1997
- Employees
- 46
- Street Address
- 31 East 62nd Street
- Mailing
- New York City, NY, 10065
- Region
- New York City, NY, US
- Reporting Currency
- USD
- Investor Line
- 212 672 9100
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 14.1
- EV/EBITDA
- 6.4
- Price/Sales
- 3.5
- Price/Book
- 1.7
Growth
- Revenue
- -31.8%
- EPS
- -60.2%
- Free Cash Flow
- 0.0%
Profitability
- Gross Margin
- 68.6%
- Operating Margin
- 25.1%
- Net Margin
- 24.6%
- ROE
- 11.3%
- ROIC
- 9.0%
Balance Sheet
- Debt/Equity
- 0.00
- Current Ratio
- 11.83
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.